Cytokinetics (CYTK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 55,600 | 5,437 | 2,843 | 6,548 | 6,722 |
| Gross Profit | 55,600 | 5,437 | 2,843 | 6,548 | 6,722 |
| Operating Expenses | 77,304 | 74,638 | 57,640 | 47,159 | 43,129 |
| Operating Income | -21,704 | -69,201 | -54,797 | -40,611 | -36,407 |
| Interest Expense | 8,489 | 7,116 | 6,944 | 6,783 | 9,669 |
| Other Income | -377 | 231 | 187 | 290 | 2,146 |
| Pre-tax Income | -30,570 | -76,086 | -61,554 | -47,104 | -43,930 |
| Net Income Continuous | -30,570 | -76,086 | -61,554 | -47,104 | -43,930 |
| Net Income | $-30,570 | $-76,086 | $-61,554 | $-47,104 | $-43,930 |
| EPS Basic Total Ops | -0.33 | -0.95 | -0.86 | -0.66 | -0.58 |
| EPS Basic Continuous Ops | -0.33 | -0.95 | -0.86 | -0.66 | -0.58 |
| EPS Diluted Total Ops | -0.33 | -0.95 | -0.86 | -0.66 | -0.58 |
| EPS Diluted Continuous Ops | -0.33 | -0.95 | -0.86 | -0.66 | -0.58 |
| EBITDA(a) | $-20,970 | $-68,739 | $-54,254 | $-40,074 | $-35,936 |